|
Join a Clinical Trial
The Society for Women’s Health Research (SWHR) was founded to bring national
attention to the problem of the exclusion of women from medical research and
clinical trials and the need for greater federal funding for diseases and
conditions prevalent in, and unique to women. Historically women had been left
out of medical research studies because doctors and scientists did not believe
there were important differences in how diseases affected men and women. These
differences are now recognized as key factors in understanding how our bodies
work and fight disease.
To help women find clinical trials in which they might like to participate,
SWHR has begun to list trials that are recruiting women for various
conditions. SWHR does not endorse or recommend any trial and is only
providing the information as a
service. Choosing to take part in a medical research study is a decision
that you make with the help of family, friends, health care professionals, and
others you trust and respect. Below you will find lists of clinical trials that
need participants, the condition the trial is studying, who qualifies, and
contact information for the research
coordinators and investigators. Additional information
about these trials and other clinical trials can be found at www.clinicaltrials.gov and www.womancando.org
Although we know more today and often take health advances for granted, much
remains to be learned. Whether you have a disease or condition that needs
treatment or are in perfect health, you can play an important role in improving
health care. By volunteering to take part in a research study, you can make a
valuable contribution to medical knowledge for your own health and the health
of all future generations of women.
Need more information? Visit our Clinical Trials FAQ page.
Click to jump to a specific topic:
Breast Cancer Studies:
www.BreastCancerTrials.org
(BCT.org) is a free, nonprofit, clinical trial matching service
that can help you quickly and easily find breast
cancer trials that might be right for you. BCT.org has
easy-to-read trial summaries and a secure message service for contacting
participating research sites. You also can sign up for their trial alert
service to learn about newly added trials that match your health history.
Back to Top
Breast Imaging Studies:
|
The Studies
|
Who qualifies
|
The Research
Coordinators
|
|
Evaluation of Low-dose Molecular Breast Imaging
as a Screening Tool. The goal of this study is to determine if a new technology
using specialized gamma cameras can detect cancers in dense breast tissue
better than mammography. |
Participants must be women, 40 years old or
older, have dense breasts on mammography and additional risk factors for breast
cancer. |
mbi@mayo.edu |
|
Evaluation of Molecular Breast Imaging in the
Detection of Breast Cancer in Patients with High Risk Benign Breast Lesions.
The goal of this study is to determine if a new technology using specialized
gamma cameras can detect cancer in women who have been diagnosed with lesions
which indicate an increased risk of developing breast cancer. |
Participants must be women, 18 years old or
older, either with recently diagnosed or history of high risk lesions of the
breast, including atypia, radial scar, or lobular carcinoma in situ. |
mbi@mayo.edu
|
|
Study of Molecular Breast Imaging in Women
Initiating or Discontinuing Hormone Therapy. This study evaluates if a new
technology using specialized gamma cameras can detect changes in breast tissue
due to use of hormone therapy. |
Participants must be women who are scheduled to
begin or stop using either 1) estrogen or 2) combination estrogen/progesterone
therapy in the form of a pill or patch. |
mbi@mayo.edu
|
Back to Top
Decreased Sexual Desire Studies:
|
The Studies
|
Who qualifies
|
The Research
Coordinators
|
|
National Registry
of Women with Decreased Sexual Desire (known as Hypoactive Sexual Desire
Disorder or HSDD). This study involves
no study related treatment or medication.
|
Participants must
be women, 18 years old or older and experiencing decreased sexual desire.
|
Pat DeHof at
pdehof@jamesasimonmd.com or 202-293-1000
|
|
A Novel
Non-hormonal Therapy for Decreased Sexual Desire (known as Hypoactive Sexual
Desire Disorder or HSDD) in Premenopausal Women.
|
Participants must
be premenopausal women, 18 years old or older and experiencing decreased sexual
desire.
|
Carol Mack at
cmack@jamesasimonmd.com or 202-293-1000
|
|
A Novel
Non-hormonal Therapy for Decreased Sexual Desire (known as Hypoactive Sexual
Desire Disorder or HSDD) in Postmenopausal Women.
|
Participants must
be postmenopausal women experiencing decreased sexual desire.
|
Pat DeHof at
pdehof@jamesasimonmd.com or 202-293-1000
|
|
Testosterone Gel
Therapy in the Treatment of Decreased Sexual Desire (known as Hypoactive
Sexual Desire Disorder or HSDD) in Postmenopausal Women after
Hysterectomy with Removal of the Ovaries.
|
Participants must
be surgically postmenopausal women experiencing decreased sexual desire.
|
Carol Mack at
cmack@jamesasimonmd.com or 202-293-1000
|
| Testosterone Gel
in the Treatment of Decreased Sexual Desire (known as Hypoactive Sexual Desire
Disorder or HSDD) in Postmenopausal Women with Cardiac
Risk Factors (high blood pressure, elevated cholesterol, etc.
|
Participants must
be postmenopausal women who have at least one cardiac risk factor, such as
high blood pressure or elevated cholesterol.
|
Carol Mack at
cmack@jamesasimonmd.com or 202-293-1000
|
Back to Top
IBS Studies:
|
The Studies
|
Who qualifies
|
The Research
Coordinators
|
|
A Placebo-Controlled Trial of Lyrica for
Irritable Bowel Syndrome (IBS). This
study involves one study visit, taking study drug or placebo for 12 weeks, and
completion of a questionnaire at home every week for 12 weeks. |
Women and men over the age of 18-70 who have
been diagnosed with irritable bowel syndrome (IBS). |
Annie
Almazar at almazarelder.ann@mayo.edu or 507-284-5010 |
Back to Top
Incontinence Studies:
|
The Studies
|
Who qualifies
|
The Research
Coordinators
|
| Randomized trial comparing Burch and
mid-urethral slings (two surgical procedures to treat urinary incontinence
related to coughing, laughing or physical activities) performed with sacral
colpopexy (a surgical procedure to correct vaginal prolapse. Also called
cystocele, rectocele, uterine prolapse or enterocele). |
Participants must be women, older than 18, have
completed childbearing, and have symptomatic pelvic organ prolapse (protrusion
of the vagina through the vaginal opening) and urinary incontinence. |
Amy Reynolds at
reynolds.amy@mayo.edu or 507-293-0018 |
| Controlled study of the use of clonidine to help
symptoms of urge fecal incontinence in women. Anorectal assessments and a
pelvic MR done at no expense. Remuneration offered.
|
Participants must be women, between 18-75 years
old, and experiencing involuntary stool leakage not associated with other
rectal disorders (rectal cancer, inflammatory bowel disease, etc.). |
Jessica Edge at edge.jessica@mayo.edu or 507-255-6802 |
Back to Top
Menopausal Symptom Studies:
|
The Studies
|
Who qualifies
|
The Research
Coordinators
|
|
Vaginal DHEA (a
naturally occurring pre-hormone) in the Treatment of Postmenopausal
Vulvar/Vaginal Atrophy
|
Participants must
be postmenopausal women ages 40-75 years old who are experiencing moderate to
severe pain at intercourse.
|
Carol Mack at
cmack@jamesasimonmd.com or 202-293-1000
|
|
An Oral SERM (a
non-estrogenic drug which acts like an estrogen or anti-estrogen depending
upon the tissue [SERM]) for the Treatment of Moderate to Severe
Postmenopausal Hot Flashes (VMS)
|
Participants must
be postmenopausal women who are experiencing sever hot flashes. If naturally
postmenopausal, participant must be 45-60 years old. If surgically postmenopausal,
participant must be 35-60 years old).
|
Pat DeHof at
pdehof@jamesasimonmd.com or 202-293-1000
|
Back to Top
Oral Contraception Studies:
|
The Studies
|
Who qualifies
|
The Research
Coordinators
|
| Oral
Contraceptives for the Prevention of Pregnancy in Normal Sexually Active
Women who are at Risk for Pregnancy.
|
Participants must
be sexually active women, 18-40 years old, who have a history of regular
menstrual cycles.
|
Carol Mack at
cmack@jamesasimonmd.com or 202-293-1000
|
| Oral
Contraceptives for the Prevention of Menstrually-Related Migraine Headaches.
|
Participants must
be women aged 18-35 years old who have a history of regular menstrual cycles
and of migraines associated with their cycles. Participants must be
non-smokers.
|
Pat DeHof at
pdehof@jamesasimonmd.com or 202-293-1000
|
| Oral Contraceptive
Use in Adolescents(12-18y): Impact on Peak Bone Density.
|
Participants must
be young women, 12-18 years old and have a history of regular menstrual
cycles (this study includes a control group which would not require the
participant to take oral contraception).
|
Pat DeHof at
pdehof@jamesasimonmd.com or 202-293-1000
|
Back to Top
More Trials |
